Literature DB >> 28847753

Sub-chronic toxicity study of arecae semen aqueous extract in Wistar rats.

Qinghua Lin1, Zhe Jia1, Xinfang Xu1, Shuya Xu1, Ting Han1, Yan Gao1, Ying Zhang1, Hui Zhang1, Huan Liu1, Jian Li2, Xiangri Li3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Arecae semen, the ripe seed of Areca catechu L., has been used as vermifuge and digestant in traditional Chinese medicine (TCM). However, the potential toxicity effect of arecae semen has not been completely investigated. THE AIM OF THE STUDY: The present study was aimed at evaluating the sub-chronic toxicity of arecae semen by oral administration in Wistar rats.
MATERIALS AND METHODS: A total of 120 Wistar rats were randomly divided into 4 groups (15 males and 15 females per group). The treated groups were given arecae semen aqueous extract (ASAE) at the dose of 750, 1500 and 4500mg/kg/day by oral administration respectively, and the control group was received distilled water only. The rats and their consumed feed were weighted every 3 days. The clinical changes and mortality were observed and recorded daily. Hematological parameters, biochemical parameters, organ weights, urinalysis and histopathological examination of all rats were tested at the end of the 30-day treatment period and another 10-day recovery period.
RESULTS: Deaths, weight loss, diarrhea, sluggish action, tremors and body curl up were observed in the 1500 and 4500mg/kg groups during the study. The relative organ weights of liver and testis in male rats of 4500mg/kg group were significantly different compared with the control group at the end of the treatment period. As for laboratory parameters, there were no significant differences at the dose of 1500 and 4500mg/kg groups compared with the control group in the study, except the white blood cell count (WBC), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin (ALB), blood urea nitrogen (BUN), creatinine (Cr), glucose (GLU) and total cholesterol (CHOL). In addition, the results of histopathological examination and feed intake showed no significant difference compared with the control group.
CONCLUSIONS: The results showed that ASAE at the dose of 750mg/kg/day was safe, but long-term oral administration of ASAE with high dosage was toxic. Moreover, the toxic ingredients of ASAE including arecoline, and also some other compounds should be researched.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Arecae semen; Arecaidine (PubChem CID: 10355); Arecaidine hydrochloride (PubChem CID: 12305194); Arecoline (PubChem CID: 2230); Arecoline hydrobromide (PubChem CID: 9301); Biochemical parameters; Guavacine (PubChem CID: 3532); Guavacine hydrochloride (PubChem CID: 11957555); Guvacoline (PubChem CID: 160492); Guvacoline hydrobromide (PubChem CID: 15560296); Hematology; Histopathology; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28847753     DOI: 10.1016/j.jep.2017.08.031

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Toxicity and Its Mechanism Study of Arecae semen Aqueous Extract in Wistar Rats by UPLC-HDMS-Based Serum Metabolomics.

Authors:  Zhe Jia; Ting Han; Qinghua Lin; Wenjia Qu; Tianying Jia; Mengnan Liu; Haili Wang; Jieping Xin; Xinfang Xu; Xiangri Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-29       Impact factor: 2.629

2.  Two New Flavonoids from the Nuts of Areca catechu.

Authors:  Mengfei Yuan; Yunlin Ao; Nan Yao; Jing Xie; Dongmei Zhang; Jian Zhang; Xiaoqi Zhang; Wencai Ye
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

3.  Toxicological Safety Evaluation in Acute and 21-Day Studies of Ethanol Extract from Solanum lyratum Thunb.

Authors:  XiaoHua Guo; LianJin Weng; LiTao Yi; Di Geng
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

4.  Acute and subacute toxicity studies of a poly herbal formulation used for diabetes.

Authors:  Aymen Owais Ghauri; Ejaz Mohiuddin; Tayyeba Rehman; Hk Sheraz Muhammad Siddiqui
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.